Cargando…
CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer
Background. Carboxypeptidase A4 (CPA4) belongs to a member of the metallocarboxypeptidase family, and its expression in lung cancer samples and clinical significance are still not investigated until now. In this study, we aimed to evaluate the level of CPA4 in non-small-cell lung cancer (NSCLC) samp...
Autores principales: | Sun, Lichao, Wang, Yipeng, Yuan, Hebao, Burnett, Joseph, Pan, Jian, Yang, Zhihua, Ran, Yuliang, Myers, Ila, Sun, Duxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934027/ https://www.ncbi.nlm.nih.gov/pubmed/27390594 http://dx.doi.org/10.7150/jca.15209 |
Ejemplares similares
-
MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer
por: Sun, Lichao, et al.
Publicado: (2019) -
Association between expression of Carboxypeptidase 4 and stem cell markers and their clinical significance in liver cancer development
por: Sun, Lichao, et al.
Publicado: (2017) -
Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer
por: Sun, Lichao, et al.
Publicado: (2017) -
Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma
por: Sun, Lichao, et al.
Publicado: (2016) -
Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells
por: Wang, Yipeng, et al.
Publicado: (2021)